Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
7.11%
operating margin TTM
12.74%
revenue TTM
256.49 Million
revenue per share TTM
1.63$
valuation ratios | |
|---|---|
| pe ratio | 264.07 |
| peg ratio | 1.05 |
| price to book ratio | 27.77 |
| price to sales ratio | 18.92 |
| enterprise value multiple | 123.11 |
| price fair value | 27.77 |
profitability ratios | |
|---|---|
| gross profit margin | 88.26% |
| operating profit margin | 12.74% |
| pretax profit margin | 7.78% |
| net profit margin | 7.11% |
| return on assets | 4.05% |
| return on equity | 12.43% |
| return on capital employed | 8.61% |
liquidity ratio | |
|---|---|
| current ratio | 6.25 |
| quick ratio | 5.03 |
| cash ratio | 1.98 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 1,043.43 |
| operating cycle | 1,186.75 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 1,186.75 |
| receivables turnover | 2.55 |
| payables turnover | 0.00 |
| inventory turnover | 0.35 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.44 |
| debt equity ratio | 1.14 |
| long term debt to capitalization | 0.52 |
| total debt to capitalization | 0.53 |
| interest coverage | 1.74 |
| cash flow to debt ratio | -0.16 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.26 |
| cash per share | 2.00 |
| operating cash flow per share | -0.26 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.16 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -900.38 |
Frequently Asked Questions
When was the last time TG Therapeutics, Inc. (NASDAQ:TGTX) reported earnings?
TG Therapeutics, Inc. (TGTX) published its most recent earnings results on 07-11-2024.
What is TG Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. TG Therapeutics, Inc. (NASDAQ:TGTX)'s trailing twelve months ROE is 12.43%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. TG Therapeutics, Inc. (TGTX) currently has a ROA of 4.05%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TGTX's net profit margin stand at?
TGTX reported a profit margin of 7.11% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TGTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 6.25 in the most recent quarter. The quick ratio stood at 5.03, with a Debt/Eq ratio of 1.14.